Table 2 Summary of the characterization of predicted damaging variants (PDVs) in NS genes in 10 ASD cases.

From: Neurometabolic profiles of autism spectrum disorder patients with genetic variants in specific neurotransmission and synaptic genes

NS pathway involved

Cases

(N)

Gene symbol

Variant type

Position

Variant

characterization

ClinVar report

SFARI gene

score

GABA

5

VPS18

SNV

15-41193187-A-G

Missensse,

Heterozygotic

Not reported in ClinVar

-

ALDH5A1

SNV

6-24528285-C-T

Stop_gain,

Heterozygotic

Pathogenic​

1 S

GAD1

SNV

2-171713633-G-A

Missensse,

Heterozygotic

VUS​

-

ALDH9A1

SNV

1-165664551-A-G

Missensse

Heterozygotic

VUS​

-

SYNE1

SNV

6-152532698-C-T

Missensse,

Heterozygotic

VUS​

2

Glutamate

6

CREBBP

SNV

16-3843551-C-T

Missensse,

Heterozygotic

Not reported in ClinVar

1 S

AKAP9

SNV

7-91630565-T-C

Missensse,

Heterozygotic

VUS​

2

EPB41L2

CNV

6-131365548-131395373

Deletion encompassing EPB41L2 gene

Not reported in ClinVar

-

RTN3

SNV

11-63487475-G-C

Missensse,

Heterozygotic

Not reported in ClinVar

-

CACNA1C

CNV

12-2115897- 2127756

Deletion encompassing CACNA1C gene

Not reported in ClinVar

1 S

PANX1

SNV

11-93886666-T-C

Missensse,

Heterozygotic

Not reported in ClinVar

-

Acetylcholine

1

CHRND

SNV

2-233396064-G-A

Missensse,

Heterozygotic

VUS

-

  1. NS: neurotransmitter and synaptic; GABA: gamma aminobutyric acid; VUS: Variants with Uncertain Significance.